SCHEMBL4034400

SCHEMBL4034400

CC(=O)OCCOc1ccc(C(CC(=O)O)CC(=O)O)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
P2RY12 Q9H244 2/20 0.39
ITGB3 P05106 1/20 0.38
ITGAV P06756 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.38
HTT P42858 1/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
APP P05067 1/20 0.37
FFAR1 O14842 2/20 0.35
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
LMNA P02545 2/20 0.35
MMP9 P14780 1/20 0.34
MMP8 P22894 1/20 0.34
MMP13 P45452 1/20 0.34
CYP2C19 P33261 1/20 0.34
TP53 P04637 1/20 0.34
CYP4F2 P78329 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4044221 0.82 PDE3B (0.39) PDE3BPDE3AP2RY12ITGB3L3MBTL1
SCHEMBL4034397 0.81 PDE3B (0.40) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL15764197 0.80 PDE3B (0.39) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL28904650 0.75 MAPT (0.51) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL30026033 0.75 MAPT (0.51) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL4044225 0.75 FFAR1 (0.50) PDE3BPDE3AP2RY12L3MBTL1FFAR1
SCHEMBL3306252 0.74 PDE3B (0.43) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL3306255 0.74 PDE3B (0.43) PDE3BPDE3AP2RY12L3MBTL1HTT
SCHEMBL10030181 0.74 L3MBTL1 (0.55) PDE3BPDE3AP2RY12L3MBTL1LMNA
SCHEMBL3300820 0.73 PDE3B (0.42) PDE3BPDE3AP2RY12L3MBTL1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2066637-A1 NOVEL SUBSTITUTED BIPYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS Bayer HealthCare AG (DE) 2009-06-10 EP disclosed
WO-2008028590-A1 NOVEL SUBSTITUTED BIPYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO disclosed